Avellino Labs
As President of Avellino Korea, Jason is responsible for managing all aspects of the company’s operations in South Korea, including supporting the implementation of growth strategies and building and maintaining client relationships. He works closely with the executive team at the company’s headquarters in Menlo Park, California, and brings in-depth knowledge and experience in Asian markets and the financial industry, including futures, options, stocks, and bonds. Jason holds a master’s degree in economics from Yonsei University and was a senior investment manager and advisor for several years prior to joining Avellino.
This person is not in any offices
Avellino Labs
Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, building on the success of the world's first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies, providing life-changing information for patient treatment decisions and follow up care. Avellino Labs is headquartered in Silicon Valley, California, with operations in Korea, Japan, China and the UK.